CVKD Institutional Ownership
Top institutional (13F) holders of CVKD and 5%+ (13D/G) positions, sourced from SEC EDGAR.
Institutional owners
8
Institutional value
$254.4K
Top holder
Vanguard Capital Management
Couldn’t find the data you were looking for?
We haven’t added Cadrenal Therapeutics, Inc.’s filings yet. We add companies and filings all the time.
Track CVKD and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Top holders
| Holder | Filed | Value |
|---|---|---|
| Vanguard Capital Managementinvestment advisor | Aug 13, 2026 | $167.5K |
| JPMORGAN CHASE & COholding company | May 13, 2026 | $31.9K |
| BlackRock, Inc.holding company | May 13, 2026 | $28.1K |
| GEODE CAPITAL MANAGEMENT, LLCinvestment advisor | Nov 6, 2026 | $20.5K |
| UBS Group AGbank | Aug 13, 2026 | $3.7K |
| MORGAN STANLEYholding company | Aug 13, 2026 | $2.4K |
| WELLS FARGO & COMPANY/MNinvestment advisor | Aug 14, 2026 | $331 |
| CITIGROUP INCinvestment advisor | May 11, 2026 | $5 |
5%+ holders
Current stakes of 5% or more from Schedule 13D and 13G filings. A joint filing shows once, under its lead filer.
No current 5%+ holders of CVKD on file.
Never miss a CVKD filing.
Get an email when CVKD files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR Schedule 13D / 13G and 13F filings.